atomoxetine liquid Strattera
Selected indexed studies
- Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers: Evidence From Human Milk Pharmacokinetic Analysis. (J Clin Psychopharmacol, 2026) [PMID:41427840]
- Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review. (Front Public Health, 2024) [PMID:39171321]
- A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples. (Biomed Chromatogr, 2012) [PMID:22275222]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers: Evidence From Human Milk Pharmacokinetic Analysis. (2026) pubmed
- Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review. (2024) pubmed
- A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples. (2012) pubmed
- Determination of atomoxetine in human plasma by a high performance liquid chromatographic method with ultraviolet detection using liquid-liquid extraction. (2007) pubmed
- Determination of atomoxetine metabolites in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study. (2012) pubmed
- A new high performance liquid chromatographic method for quantification of atomoxetine in human plasma and its application for pharmacokinetic study. (2007) pubmed
- Metabolomic and lipidomic profiling reveals convergent pathways in attention deficit hyperactivity disorder therapeutics: Insights from established and emerging treatments. (2025) pubmed
- Fatal atomoxetine overdose in Japan: a forensic autopsy case report. (2026) pubmed
- Effects of CYP2C19 genetic polymorphisms on atomoxetine pharmacokinetics. (2014) pubmed
- Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder. (2016) pubmed